IMAS Healthcare

13/02/2026

Data Check: Why “Normal Cholesterol” Isn’t the Full Story

Multiple large studies and expert reviews show that cholesterol alone is an incomplete marker of heart risk.

• Harvard Health Publishing reports that about 50% of people who experience a heart attack have cholesterol levels that would traditionally be considered “normal.”

• Experts at leading academic centers, including the Cleveland Clinic, consistently emphasize that cardiovascular risk assessment must go beyond standard lipid numbers and include factors such as inflammation, plaque burden, blood pressure, genetics, metabolic health, and lifestyle.

In other words:
Normal cholesterol does not equal zero risk.

Many heart attacks occur in people who were never flagged as having “high cholesterol.”

This is why comprehensive heart evaluations — and timely second opinions — focus on overall cardiovascular risk, not just a single lab value.

Peer-to-peer educational consultations with the Cleveland Clinic experts go beyond cholesterol, integrating imaging, genetics(where applicable), lifestyle, and individualized, specific risk factors to give you a complete picture of your true cardiovascular risk.

To schedule your peer-to-peer educational consultations, reach out to us at [email protected].

06/02/2026

When every breath feels like a question, expert guidance truly matters.

For patients living with complex lung conditions—especially when conversations turn toward lung transplantation—clarity can be life-changing.

At IMAS Healthcare, we see this need every day. Nearly 36% of pulmonology consultations we facilitate relate to lung transplant evaluation or eligibility—often at moments marked by uncertainty, fear, and difficult decisions.

Through IMAS Healthcare, patients in India can access peer-to-peer educational consultations with global experts from the Cleveland Clinic, without the need to travel initially.

One such expert is Atul C. Mehta, Transplant Pulmonologist at Cleveland Clinic and Founder of the American Association for Bronchology—widely regarded as a leading authority in advanced lung care and transplant evaluation.

With conditions such as interstitial lung disease (ILD) affecting an estimated 4–9 lakh people in India, timely access to specialised, global expertise has never been more important.

This Cleveland Clinic patient story from India illustrates what expert-led evaluation and care can make possible, including lung transplantation:

Link - https://www.youtube.com/watch?v=BfgbUfmNF2E

If you are:

1. Seeking clarity about a lung condition

2. Unsure whether lung transplantation may be an option

3. Looking for trusted expert guidance before taking the next step

Reach out to us at [email protected]. Because better conversations lead to better decisions—and sometimes, to new breath.

My email address is [email protected] please don't hesitate to email me if you have any questions !!I was diagnosed with Scleroderma in my youth. At the ...

23/01/2026

While breast cancer is often perceived as a disease that affects women, male breast cancer is rare in India — accounting for less than 1% of all breast cancer cases — and low awareness often leads to delayed diagnosis. (Source – Times of India).

A patient reached out to IMAS Healthcare for a second opinion on lung cancer treatment. What followed was unexpected. A closer expert review revealed a rare case of male breast cancer, changing the diagnosis and the treatment direction entirely.

This is why second opinions can be life-changing. Not just to confirm what’s already been said, but to pause, look deeper, and make sure the right condition is being treated in the right way, at the right time.

At IMAS Healthcare, we help patients and families access peer-to-peer educational consultations with experts from the Cleveland Clinic, so they can better understand their diagnosis and treatment options — without the stress of travelling.

The video below offers a look into the Breast Cancer Clinic at Cleveland Clinic Abu Dhabi, showcasing the advanced technologies and patient-centred care.

Link - https://youtu.be/nUWOy6wGl9k?si=xU2UwUFF5ji0wkKZ

IMAS Healthcare doesn’t replace care. We strengthen clinical decisions. So patients can move forward with confidence, not assumptions.

For more information, reach out to us at [email protected].

For the most common type of cancer among women in the UAE and the world, breast cancer, treatment is more successful if it’s caught early. Regular screening ...

16/01/2026

For thousands of patients in India, the wait for a life-saving organ transplant often extends beyond the time they can afford.

According to the National Organ & Tissue Transplant Organization (NOTTO) annual report published in mid-2024, only 197 lung transplants were performed in India in 2023, while 1,771 patients were awaiting a lung transplant as of September 2024 — highlighting the significant gap between demand and availability.

For patients with end-stage lung disease, timely access to specialised transplant expertise can be the difference between survival and loss.

IMAS Healthcare helps bridge this critical information gap by enabling peer-to-peer educational consultations, supporting patients and families with clarity on diagnosis, transplant eligibility, and possible care pathways before key decisions are made.

This video highlights the journey of Mr. Rohith, an Indian patient who travelled to Cleveland Clinic Abu Dhabi and successfully underwent a lung transplant — demonstrating what becomes possible when patients have access to advanced transplant expertise.

Watch full video here ----> https://youtu.be/EkS9N0k9B6w

Through IMAS Healthcare, many patients with advanced lung disease have sought peer-to-peer educational consultations to better understand their options — because every patient deserves informed guidance, at the right time.

For more information, reach out to [email protected].

Rohit’s journey is one of determination, resilience, and the will to keep moving forward.After years of struggling to breathe due to advanced interstitial lu...

09/01/2026

Because when it comes to the heart, clarity is not a luxury — it’s essential.

Nearly 1 in 3 patients who contact IMAS Healthcare are seeking clarity about a heart condition.

Not just what the diagnosis is — but what it really means for their life.

Patients often ask us:
• Do I need surgery right now, or can this wait?
• Is open-heart surgery my only option?
• Is there a less invasive or non-surgical approach?
• Am I being overtreated… or undertreated?

These are not small questions.
They affect families, finances, and peace of mind.

This is where IMAS Healthcare helps.

We connect Indian patients with world-renowned heart specialists from the Cleveland Clinic Heart and Vascular Institute for virtual second opinions — so you can make informed decisions without rushing or travelling.

If travel does become necessary, IMAS Healthcare stays with you every step of the way:

• Scheduling doctor appointments
• Helping plan travel and care
• On-ground support at Cleveland Clinic locations in the U.S., London, and Abu Dhabi

IMAS Healthcare does not replace your doctor. We help you strengthen your decision — so you move forward with confidence, not doubt.

Because peace of mind matters as much as treatment.

📩 To learn more, reach out to [email protected].

20/10/2025

HAPPY DIWALI 🪔

24/09/2025

Celebrating a breakthrough in cardiovascular care at Cleveland Clinic Abu Dhabi – now the first hospital in the Middle East to perform a minimally invasive Thoracic Branch Endoprosthesis (TBE) procedure for Type B aortic dissection.

This groundbreaking technology, led by Dr.Houssam Younes, Division Chair of Vascular Surgery, utilizes the TBE device to preserve blood flow to the brain and left arm while avoiding open-chest surgery, thereby reducing risks such as stroke and nerve injury.

The result: faster recovery, shorter ICU stay, and a quicker return to daily life.

For more information on advanced cardiovascular care at Cleveland Clinic Abu Dhabi, contact us at [email protected].

20/08/2025

Celebrating a breakthrough in prostate care at Cleveland Clinic Abu Dhabi – now the first in the UAE to offer Aquablation therapy for Benign Prostatic Hyperplasia (BPH).

This robotic-assisted treatment uses the AquaBeam® Robotic System to precisely remove excess prostate tissue with a high-pressure waterjet – ensuring minimal side effects, faster recovery, and lasting relief, even for patients with complex conditions.

Cleveland Clinic Abu Dhabi continues to transform urological care with safer, more advanced solutions that improve long-term outcomes and quality of life.

For more information on advanced urology care, contact us at [email protected].

We’re proud to be the first in the UAE to offer Aquablation therapy—a game-changer in prostate care. This is a breakthrough, robotic-assisted treatment for Benign Prostatic Hyperplasia (BPH) using the AquaBeam® Robotic System to deliver unmatched precision, setting a new standard for safety and...

14/08/2025